Sahsine Tolunay

Sahsine Tolunay

Auto-generated profile, based on publicly available information

Sahsine Tolunay

Department of Pathology, Faculty of Medicine, Bursa Uludag University, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in European Journal of Breast Health
Verified
Journal Article
Closed access
SHSecil Hasdemir
Secil Hasdemir
STSahsine Tolunay
Sahsine Tolunay
MOMine Ozsen
Mine Ozsen
MGMustafa Sehsuvar Gokgoz
Mustafa Sehsuvar Gokgoz
Eur J Breast Health AVES | Copyright © 2017 Türkiye Meme Hastalıkları Dernekleri Federasyonu |

7 December 2006 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
BTBerrin Tunca
Berrin Tunca
ABAhmet Bekar
Ahmet Bekar
GCGulsah Cecener
Gulsah Cecener
ÜEÜnal Egeli
Ünal Egeli
ÖZGÜR VATANÖZGÜR VATAN
ÖZGÜR VATAN
KAKaya Aksoy
Kaya Aksoy

1 January 2018 in Turkish Journal of Pathology
Verified
Journal Article
Open access
MOMine Ozsen
Mine Ozsen
STSahsine Tolunay
Sahsine Tolunay
MGM. Sehsuvar Gokgoz
M. Sehsuvar Gokgoz
Granulomatous lobular mastitis is a rare benign chronic breast disease first described by Milward in 1970, and then by Kessler and Wolloch in 1972. In this study, we aimed to present clinicopathologic features of granulomatous lobular mastitis with literature data. In this study, the archives of Uludag University Medical Faculty Department of Pathology were screened for granulomatous lobular mastitis cases between 2005 and 2017. A total of 90 patients with granulomatous lobular mastitis diagnosed between 2005 and 2017 were identified. All of the cases were female. The mean age was 34+8.3 (range 21-60 years). There was sarcoidosis in one case and tuberculosis in another case, but no systemic disease was found in the charts of the other cases. Histopathological evaluation of 90 cases revealed non-necrotizing granulomas involving lobule-restricted, epithelioid histiocytes and Langhans-type multinuclear giant cells. There was no case of necrosis, including our only case with a history of tuberculosis. We conclude that our granulomatous lobular mastitis cases have similar characteristics with the series reported earlier, when all features are taken into consideration.

29 June 2018 in European Journal of Breast Health
Verified
Journal Article
Open access
MOMine Ozsen
Mine Ozsen
STSahsine Tolunay
Sahsine Tolunay
MGM. Sehsuvar Gokgoz
M. Sehsuvar Gokgoz
Granulomatous lobular mastitis is a rare chronic breast disease, firstly described by Kessler and Wolloch in 1972. In this article we present a 35-year-old patient with granulomatous lobular mastitis and in situ ductal carcinoma and discuss clinicopathological characteristics of the disease with literature data. A 35-year-old female patient admitted to the outpatient clinic with a complaint of swelling in right breast ongoing since March 2017. On the basis of physical examination and radiological examinations, antibiotic therapy was initiated considering the inflammatory breast disease and the patient was referred to our general surgery clinic because she did not benefit from treatment. On the recommendation of histopathological correlation, trucut biopsy was performed and reported as granulomatous mastitis. In the histopathological examination of the prepared sections, we found lobule-restricted, non-caseous granulomas and neoplastic epithelial cell proliferation in 4 different foci, the largest being 0.7×0.4 cm in diameter, limited to the ductal lobular system. The case was diagnosed as granulomatous lobular mastitis and in situ ductal carcinoma. This lesion, which clinically and radiologically can be confused with carcinoma, rarely coexists with breast carcinoma. Our case demonstrates the coexistence of granulomatous lobular mastitis and in situ ductal carcinoma.

1 March 2011 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
OTO. Taskapilioglu
O. Taskapilioglu
SYS. Yurtogullari
S. Yurtogullari
EYEmel Yilmaz
Emel Yilmaz
BHB. Hakyemez
B. Hakyemez
SYS. Yilmazlar
S. Yilmazlar
IBI. Bora
I. Bora

5 February 2020 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
OAOmer Gokay Argadal
Omer Gokay Argadal
MMMelis Mutlu
Melis Mutlu
SASecil Ak Aksoy
Secil Ak Aksoy
HKHasan Kocaeli
Hasan Kocaeli
BTBerrin Tunca
Berrin Tunca
STSahsine Tolunay
Sahsine Tolunay
Primary glioblastoma (GB) is the most aggressive type of brain tumors. While mutations in isocitrate dehydrogenase (IDH) genes are frequent in secondary GBs and correlate with a better prognosis, most primary GBs are IDH wild-type. Recent studies have shown that the long noncoding RNA metastasis associated lung adenocarcinoma transcript-1 (MALAT1) is associated with aggressive tumor phenotypes in different cancers. Our aim was to clarify the prognostic significance of MALAT1 in IDH1/2 wild-type primary GB tumors. We analyzed IDH1/2 mutation status in 75 patients with primary GB by DNA sequencing. The expression of MALAT1 was detected in the 75 primary GB tissues and 5 normal brain tissues using reverse transcription quantitative PCR (RT-qPCR). The associations between MALAT1 expression, IDH1/2 mutation status, and clinicopathological variables of patients were determined. IDH1 (R132H) mutation was observed in 5/75 primary GBs. IDH2 (R172H) mutation was not detected in any of our cases. MALAT1 expression was significantly upregulated in primary GB vs. normal brain tissues (p = 0.025). Increased MALAT1 expression in IDH1/2 wild-type primary GBs correlated with patient age and tumor localization (p = 0.032 and p = 0.025, respectively). A multivariate analysis showed that high MALAT1 expression was an unfavorable prognostic factor for overall survival (p = 0.034) in IDH1/2 wild-type primary GBs. High MALAT1 expression may have a prognostic role in primary GBs independent of IDH mutations.